Stocks rise in quiet trading day... 📈

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

Here’s what moved the market today.

Markets 📈

The stock market continued to trend higher on Wednesday, albeit with small fractional gains.

Sponsored

Ben Stein FREE Report: How Americans Are RUINING Retirement

Rising interest rates... Skyrocketing inflation... Exploding debt... A looming recession...

It's no wonder Americans are becoming concerned about their savings and investments.

That's why Ben Stein wrote his newest report...

This FREE REPORT shows YOU how you could protect your retirement savings before it's too late.

Get started now to see how you can protect everything you've worked for!

Access the Guide on the Next Page >>

Market-Moving News 🔎 

⚖ NYT Sues MSFT and OpenAI

The New York Times [NYT ] has initiated a significant lawsuit against Microsoft [MSFT ] and OpenAI in a case centering around alleged copyright infringement.

The complaint has put a spotlight on the burgeoning field of generative AI technologies and their impact on the news publishing industry.

🤖 Core of the Dispute:
The Times accuses both Microsoft and OpenAI of using its content without authorization to develop AI products like OpenAI's ChatGPT and Microsoft's Copilot.

According to the lawsuit, millions of pieces of content from the Times were utilized in training these AI tools, which allegedly leverage this material to respond to user queries.

🔍 Broader Implications:
This legal action marks a new phase in the ongoing conflict over internet economics, bringing into confrontation a major news entity and leading figures in AI innovation.

The lawsuit follows unsuccessful commercial discussions between the New York Times and the tech companies.

Cytokinetics [CYTK] $83.45 (+82.5%)
said aficamten met its primary endpoint in a SEQUOIA-HCM Phase 3 trial for heart disease.

Cingulate [CING] $3.99 (+101.5%)
rebounded suddenly in what appeared to be a natural correction after a long row of losses.

Eloxx Pharma [ELOX] $1.29 (+51.7%)
confirmed that its ELX-02 drug candidate produced improvements in patients with Alport Syndrome.

Bluejay Diagnostics [BJDX] $1.76 (32.5%)
launched a clinical study to evaluate its Symphony interleukin-6 test in sepsis patients.

Ebix [EBIX] $1.16 (32.1%)
continues to slide in the wake of a recent Chapter 11 filing for its U.S.-only business arm.

Airship AI [AISP] $2.58 (25.8%) 
fell in its first day of trading since completing its business combination with BYTE Acquisition Corp SPAC.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Text ELITESTOCKS to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.